2026 NPPES data Hematology & Oncology Physician NPI 1184620122 M.D.
Verify on CMS →

FREDERICK BARR, M.D.

Hematology & Oncology Physician in CHEVY CHASE, Maryland. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
533
Medicare Part D claims · 86 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
73%
generic claims · 27% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
89.0361/100
▲ 6 pts above national avg 83.1 · [object Object]
Industry payments
$4.0K
157 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: FREDERICK BARR, M.D. is a Hematology & Oncology Physician ([object Object]) practicing in CHEVY CHASE, Maryland with a Medicare Part D prescribing footprint of 533 claims across 86 beneficiaries — 27% brand-name prescribing . Their CMS MIPS Final Score of 89.0361/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $4.0K across 157 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: FREDERICK BARR, M.D. reported a CMS MIPS final score of 89.0361 out of 100, above the 83.1 national average, and filed 533 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

FREDERICK BARR, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

FREDERICK BARR, M.D. at a glance

High performer (top quartile)

NPI registry status

Active

Issued 06/23/2005

NPI 1184620122

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

533 37% vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

89.0361/100 5.93610000000001% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Maryland

How Hematology & Oncology Physician compares to other specialties among Maryland providers

Maryland providers

Hematology & Oncology Physician share within Maryland

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Maryland

Medicare quality performance — MIPS

FREDERICK BARR, M.D.'s 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

High performer (top quartile)
MIPS Final Score
89.0361/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Hematology & Oncology Physician) — 89.0361/100 vs national avg 83.1

0%100%National avg83%89%
MIPS final score (Hematology & Oncology Physician) — 89.0361/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

FREDERICK BARR, M.D. is a Hematology & Oncology Physician provider practicing in CHEVY CHASE, Maryland, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1184620122. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

FREDERICK BARR, M.D. appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding M.D. credentials at 5454 WISCONSIN AVE, CHEVY CHASE, MD, 20815, with a listed phone of (301) 657-8587. NPI 1184620122 was issued on 06/23/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BARR most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 533 prescription claims written by this provider, covering 86 Medicare beneficiaries and totaling roughly $1.4 million in drug spend, split 27% brand-name and 73% generic by claim count, with an opioid prescribing rate of 4.1%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 89.0361/100 for the 2023 performance year (Quality 72.5903, Cost 100), compared with the national average of 83.1.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

5454 WISCONSIN AVE
CHEVY CHASE, MD 20815

Provider Details

NPI 1184620122
Specialty Hematology & Oncology Physician
Credentials M.D.
Gender Male
NPI Issued 06/23/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

89.0361
Final Score
Avg: 83.1
72.5903
Quality
100
Cost

Reporting: Group practice

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for FREDERICK BARR, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$4.0K

Largest payer

AstraZeneca Pharmaceuticals LP

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Above average

FREDERICK BARR, M.D. — brand share 27.0%
Specialty average (est.)

27% brand-name claims vs 73% generic, on 533 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

533
Total Claims
$1.4M
Total Drug Cost
86
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,147
Total Day Supply
33,613
Brand vs Generic
27% brand / 73% generic
Brand Drug Cost
$1.1M
Generic Drug Cost
$337K
Opioid Claims
22 (4.1% rate)

Patient Demographics

Average Patient Age
77.1 years
Avg HCC Risk Score
1.29
Gender Split
70% female / 30% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Anastrozole
53
Jakafi
Ruxolitinib Phosphate
35
Eliquis
Apixaban
19
Prednisone
15
Revlimid
Lenalidomide
14
Letrozole
13
Lisinopril
13
Rosuvastatin Calcium
13
Xarelto
Rivaroxaban
13
Alprazolam
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How FREDERICK BARR, M.D. fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

FREDERICK BARR, M.D.'s 533 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Maryland

Other clinicians with the same primary specialty enrolled in Maryland, drawn from the same CMS NPPES roster as BARR.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is FREDERICK BARR, M.D.'s specialty?
FREDERICK BARR, M.D. specializes in Hematology & Oncology Physician and practices in CHEVY CHASE, Maryland. Credentials: M.D..
How much does FREDERICK BARR, M.D. prescribe under Medicare Part D?
In 2023, FREDERICK BARR, M.D. wrote 533 Medicare Part D claims totaling $1.4M in drug costs for 86 beneficiaries.
What is FREDERICK BARR, M.D.'s Medicare quality score?
FREDERICK BARR, M.D. has a CMS MIPS Final Score of 89.0361/100 (Quality: 72.5903, Cost: 100). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is FREDERICK BARR, M.D. located?
FREDERICK BARR, M.D. is located at 5454 WISCONSIN AVE, CHEVY CHASE, MD, 20815. Phone: (301) 657-8587.
What is FREDERICK BARR, M.D.'s NPI number?
FREDERICK BARR, M.D.'s National Provider Identifier (NPI) is 1184620122, issued on 06/23/2005.
Does FREDERICK BARR, M.D. prescribe more brand-name or generic drugs?
FREDERICK BARR, M.D.'s prescribing is 27% brand-name and 73% generic drugs by claim count, with $1.1M in brand drug costs.
Does FREDERICK BARR, M.D. prescribe opioids?
Yes, FREDERICK BARR, M.D. had 22 opioid claims in 2023 with an opioid prescribing rate of 4.1%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does FREDERICK BARR, M.D. prescribe most often?
Based on 2023 Medicare Part D data, FREDERICK BARR, M.D.'s most frequently prescribed drugs include Anastrozole, Jakafi, Eliquis. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does FREDERICK BARR, M.D. accept Medicare?
FREDERICK BARR, M.D. appears in CMS Medicare data with 533 Part D claims and 86 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify FREDERICK BARR, M.D.'s credentials?
FREDERICK BARR, M.D.'s NPI is 1184620122 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology